83_FR_26796 83 FR 26685 - Request for the Technical Review of 3 Draft Immediately Dangerous to Life or Health (IDLH) Value Profiles

83 FR 26685 - Request for the Technical Review of 3 Draft Immediately Dangerous to Life or Health (IDLH) Value Profiles

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 83, Issue 111 (June 8, 2018)

Page Range26685-26686
FR Document2018-12364

The National Institute for Occupational Safety and Health of the Centers for Disease Control and Prevention announces the availability of three (3) draft Immediately Dangerous to Life or Health (IDLH) Value Profiles now available for public comment for the chemicals bromine trifluoride, chlorine trifluoride, and ethylene dibromide. To view the notice and related materials, visit www.regulations.gov and enter CDC-2018-0055 in the search field and click ``Search.''

Federal Register, Volume 83 Issue 111 (Friday, June 8, 2018)
[Federal Register Volume 83, Number 111 (Friday, June 8, 2018)]
[Notices]
[Pages 26685-26686]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-12364]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Docket Number CDC-2018-0055, NIOSH 156-D]


Request for the Technical Review of 3 Draft Immediately Dangerous 
to Life or Health (IDLH) Value Profiles

AGENCY: National Institute for Occupational Safety and Health (NIOSH) 
of the Centers for Disease Control and Prevention (CDC),

[[Page 26686]]

Department of Health and Human Services (HHS).

ACTION: Request for comments.

-----------------------------------------------------------------------

SUMMARY: The National Institute for Occupational Safety and Health of 
the Centers for Disease Control and Prevention announces the 
availability of three (3) draft Immediately Dangerous to Life or Health 
(IDLH) Value Profiles now available for public comment for the 
chemicals bromine trifluoride, chlorine trifluoride, and ethylene 
dibromide. To view the notice and related materials, visit 
www.regulations.gov and enter CDC-2018-0055 in the search field and 
click ``Search.''

Table of Contents

 Dates
 Addresses
 For Further Information Contact
 Supplementary Information
 Background
 Reference

DATES: Electronic or written comments must be received by August 7, 
2018.

ADDRESSES: You may submit comments, identified by CDC-2018-0055 and 
docket number NIOSH 156-D, by any of the following methods:
     Federal eRulemaking Portal: http://www.regulations.gov. 
Follow the instructions for submitting comments.
     Mail: National Institute for Occupational Safety and 
Health, NIOSH Docket Office, 1090 Tusculum Avenue, MS C-34, Cincinnati, 
Ohio 45226-1998.
    Instructions: All information received in response to this notice 
must include the agency name and docket number [CDC-2018-0055; NIOSH 
156-D]. All relevant comments received will be posted without change to 
www.regulations.gov, including any personal information provided. For 
access to the docket to read background documents or comments received, 
go to www.regulations.gov. All information received in response to this 
notice will also be available for public examination and copying at the 
NIOSH Docket Office, 1150 Tusculum Avenue, Room 155, Cincinnati, OH 
45226-1998.

FOR FURTHER INFORMATION CONTACT:  R. Todd Niemeier, NIOSH, Robert A. 
Taft Laboratories, MS-C32, 1090 Tusculum, Cincinnati, OH 45226, 
telephone (513) 533-8166 (not a toll free number).

SUPPLEMENTARY INFORMATION: NIOSH is requesting technical reviews of the 
three (3) draft IDLH Value Profiles. To facilitate the review of these 
documents, NIOSH requests that the following questions be taken into 
consideration:
    1. Does this document clearly outline the health hazards associated 
with acute (or short-term) exposures to the chemical? If not, what 
specific information is missing from the document?
    2. Are the rationale and logic behind the derivation of an IDLH 
value for a specific chemical clearly explained? If not, what specific 
information is needed to clarify the basis of the IDLH value?
    3. Are the conclusions supported by the data?
    4. Are the tables clear and appropriate?
    5. Is the document organized appropriately? If not, what 
improvements are needed?
    6. Are you aware of any scientific data reported in governmental 
publications, databases, peer-reviewed journals, or other sources that 
should be included within this document?
    NIOSH seeks comments on 3 draft IDLH values and IDLH Value 
Profiles. The draft IDLH Value Profiles were developed to provide the 
scientific rationale behind derivation of IDLH values for the following 
chemicals:

------------------------------------------------------------------------
         Document No.                  Chemical             CAS No.
------------------------------------------------------------------------
C-01..........................  Bromine Trifluoride..        (7787-71-5)
C-02..........................  Chlorine Trifluoride.        (7790-91-2)
C-03..........................  Ethylene Dibromide...         (106-93-4)
------------------------------------------------------------------------

    Each IDLH Value Profile provides a detailed summary of the health 
hazards of acute exposures to high airborne concentrations and the 
rationale for the proposed IDLH value with the chemical(s) of interest.
    Background: In 2013, NIOSH published Current Intelligence Bulletin 
(CIB) 66--Derivation of Immediately Dangerous to Life or Health (IDLH) 
Values [NIOSH 2013]. Since the establishment of the IDLH values in the 
1970s, NIOSH has continued to review available scientific data to 
improve the protocol used to derive acute exposure guidelines, in 
addition to the chemical-specific IDLH values. The information 
presented in this CIB represents the most recent update of the 
scientific rationale and the methodology (hereby referred to as the 
IDLH methodology) used to derive IDLH values. The primary objectives of 
this document are to:
    1. Provide a brief history of the development of IDLH values.
    2. Update the scientific bases and risk assessment methodology used 
to derive IDLH values from quality data.
    3. Provide transparency behind the rationale and derivation process 
for IDLH values.
    4. Demonstrate how scientifically credible IDLH values can be 
derived from available data resources.
    The IDLH methodology is based on a weight-of-evidence approach that 
applies scientific judgment for critical evaluation of the quality and 
consistency of scientific data and in extrapolation from the available 
data to the IDLH value. The weight-of-evidence approach refers to 
critical examination of all available data from diverse lines of 
evidence and the derivation of a scientific interpretation on the basis 
of the collective body of data, including its relevance, quality, and 
reported results. Conceptually, the derivation process for IDLH values 
is similar to that used in other risk-assessment applications, 
including these steps:
    1. Hazard characterization.
    2. Identification of critical adverse effects.
    3. Identification of a POD.
    4. Application of appropriate UFs, based on the study and POD.
    5. Determination of the final risk value.

Reference

NIOSH [2013]. Current Intelligence Bulletin 66: Derivation of 
immediately dangerous to life or health (IDLH) values. Cincinnati, 
OH: U.S. Department of Health and Human Services, Centers for 
Disease Control and Prevention, National Institute for Occupational 
Safety and Health, DHHS (NIOSH) Publication 2014-100.

    Dated: June 5, 2018.
John J. Howard,
Director, National Institute for Occupational Safety and Health, 
Centers for Disease Control and Prevention.
[FR Doc. 2018-12364 Filed 6-7-18; 8:45 am]
 BILLING CODE 4163-19-P



                                                                               Federal Register / Vol. 83, No. 111 / Friday, June 8, 2018 / Notices                                                  26685

                                              DEPARTMENT OF HEALTH AND                                accessible, equitable, and affordable,                   The Council meets in the Washington,
                                              HUMAN SERVICES                                          and to work within the U.S. Department                 DC, metropolitan area, generally in
                                                                                                      of Health and Human Services and with                  Rockville, Maryland, approximately
                                              Agency for Healthcare Research and                      other partners to make sure that the                   three times a year to provide broad
                                              Quality                                                 evidence is understood and used.                       guidance to the Secretary and AHRQ’s
                                                                                                      DATES: Nominations should be received                  Director on the direction of and
                                              Agency Information Collection                                                                                  programs undertaken by AHRQ.
                                              Activities: Proposed Collection;                        on or before 60 days after date of
                                                                                                      publication.                                             Seven individuals will be selected by
                                              Comment Request; Correction                                                                                    the Secretary to serve on the Council
                                                                                                      ADDRESSES:    Nominations should be sent               beginning with the meeting in the
                                              AGENCY: Agency for Healthcare Research
                                                                                                      to Jaime Zimmerman AHRQ, 5600                          spring of 2019. Members generally serve
                                              and Quality (AHRQ), Department of
                                                                                                      Fishers Lane, 06E37A, Rockville,                       3-year terms. Appointments are
                                              Health and Human Services.
                                                                                                      Maryland 20857. Nominations may also                   staggered to permit an orderly rotation
                                              ACTION: Notice, correction.                             be emailed to                                          of membership.
                                              SUMMARY:   The Agency for Healthcare                    NationalAdvisoryCouncil@ahrq.hhs.gov.                    Interested persons may nominate one
                                              Research and Quality published a                        FOR FURTHER INFORMATION CONTACT:                       or more qualified persons for
                                              correction document in the Federal                      Jaime Zimmerman, AHRQ, at (301) 427–                   membership on the Council. Self-
                                              Register of May 29, 2018 regarding                      1456.                                                  nominations are accepted. Nominations
                                              AHRQ Seeking Input on Library of                        SUPPLEMENTARY INFORMATION: 42 U.S.C.                   shall include: (1) A copy of the
                                              Patient-Centered Outcomes Research                      299c establishes a National Advisory                   nominee’s resume or curriculum vitae;
                                              Resources. This document contained an                   Council for Healthcare Research and                    and (2) a statement that the nominee is
                                              error in the email address where                        Quality (the Council). Seven current                   willing to serve as a member of the
                                              comments should be submitted.                           members’ terms will expire in                          Council. Selected candidates will be
                                              FOR FURTHER INFORMATION CONTACT:                        November 2018. To fill these positions,                asked to provide detailed information
                                              Carla Ladner at 301–427–1205 or                         we are seeking individuals who are                     concerning their financial interests,
                                              AHRQ_Fed_Register@ahrq.hhs.gov.                         distinguished in: (1) The conduct of                   consultant positions and research grants
                                                                                                      research, demonstration projects, and                  and contracts, to permit evaluation of
                                              Correction                                                                                                     possible sources of conflict of interest.
                                                                                                      evaluations with respect to health care;
                                                In the correction to the Federal                      (2) the fields of health care quality                  Please note that once a candidate is
                                              Register of May 29, 2018, in FR Doc                     research or health care improvement; (3)               nominated, AHRQ may consider that
                                              2018–11472, on page 1, line 29, correct                 the practice of medicine; (4) other                    nomination for future positions on the
                                              the caption under ADDRESSES to read:                    health professions; (5) representing the               Council.
                                              Electronic responses are preferred and                  private health care sector (including                    The Department seeks a broad
                                              should be sent to: PCORResources@                       health plans, providers, and purchasers)               geographic representation. In addition,
                                              ahrq.hhs.gov.                                           or administrators of health care delivery              AHRQ conducts and supports research
                                                Dated: June 4, 2018.                                  systems; (6) the fields of health care                 concerning priority populations, which
                                              Carla M. Ladner,                                        economics, information systems, law,                   include: Low-income groups; minority
                                              Correspondence Analyst/Federal Register                 ethics, business, or public policy; and,               groups; women; children; the elderly;
                                              Liaison—AHRQ.                                           (7) representing the interests of patients             and individuals with special health care
                                              [FR Doc. 2018–12312 Filed 6–7–18; 8:45 am]              and consumers of health care. 42 U.S.C.                needs, including individuals with
                                                                                                      299c(c)(2).                                            disabilities and individuals who need
                                              BILLING CODE 4160–90–P
                                                                                                         Individuals are particularly sought                 chronic care or end-of-life health care.
                                                                                                      with experience and success in                         See 42 U.S.C. 299(c). Nominations of
                                              DEPARTMENT OF HEALTH AND                                activities specified in the summary                    persons with expertise in health care for
                                              HUMAN SERVICES                                          above. 42 U.S.C. 299c provides that the                these priority populations are
                                                                                                      Secretary shall appoint to the National                encouraged.
                                              Agency for Healthcare Research and                      Advisory Council for Healthcare                        Francis D. Chesley, Jr.,
                                              Quality                                                 Research and Quality twenty one                        Acting Deputy Director.
                                                                                                      appropriately qualified individuals. At
                                              Agency Information Collection                                                                                  [FR Doc. 2018–12361 Filed 6–7–18; 8:45 am]
                                                                                                      least seventeen members shall be
                                              Activities: Proposed Collection;                        representatives of the public and at least             BILLING CODE 4160–90–P
                                              National Advisory Council for                           one member shall be a specialist in the
                                              Healthcare Research and Quality:                        rural aspects of one or more of the
                                              Request for Nominations for Public                                                                             DEPARTMENT OF HEALTH AND
                                                                                                      professions or fields listed in the above              HUMAN SERVICES
                                              Members                                                 summary. In addition, the Secretary
                                              AGENCY: Agency for Healthcare Research                  designates, as ex officio members,                     Centers for Disease Control and
                                              and Quality (AHRQ), HHS.                                representatives from other Federal                     Prevention
                                              ACTION: Notice of request for                           agencies, principally agencies that
                                                                                                      conduct or support health care research,               [Docket Number CDC–2018–0055, NIOSH
                                              nominations for public members.                                                                                156–D]
                                                                                                      as well as Federal officials the Secretary
                                              SUMMARY:   The Council is to advise the                 may consider appropriate. 42 U.S.C.
amozie on DSK3GDR082PROD with NOTICES1




                                                                                                                                                             Request for the Technical Review of 3
                                              Secretary of HHS (Secretary) and the                    299c(c)(3). Consistent with revised                    Draft Immediately Dangerous to Life or
                                              Director of the Agency for Healthcare                   guidance regarding the ban on lobbyists                Health (IDLH) Value Profiles
                                              Research and Quality (AHRQ) on                          serving as members of advisory boards
                                              matters related to activities of the                    and commissions, AHRQ will accept                      AGENCY:  National Institute for
                                              Agency to carry out its mission. AHRQ’s                 nominations for Federally-registered                   Occupational Safety and Health
                                              mission is to produce evidence to make                  lobbyists to serve on the Council in a                 (NIOSH) of the Centers for Disease
                                              health care safer, higher quality, more                 representative capacity.                               Control and Prevention (CDC),


                                         VerDate Sep<11>2014   16:53 Jun 07, 2018   Jkt 241001   PO 00000   Frm 00045   Fmt 4703   Sfmt 4703   E:\FR\FM\08JNN1.SGM   08JNN1


                                              26686                                        Federal Register / Vol. 83, No. 111 / Friday, June 8, 2018 / Notices

                                              Department of Health and Human                                               • Federal eRulemaking Portal: http://                                facilitate the review of these documents,
                                              Services (HHS).                                                           www.regulations.gov. Follow the                                         NIOSH requests that the following
                                              ACTION:      Request for comments.                                        instructions for submitting comments.                                   questions be taken into consideration:
                                                                                                                           • Mail: National Institute for                                         1. Does this document clearly outline
                                              SUMMARY:    The National Institute for                                    Occupational Safety and Health, NIOSH                                   the health hazards associated with acute
                                              Occupational Safety and Health of the                                     Docket Office, 1090 Tusculum Avenue,                                    (or short-term) exposures to the
                                              Centers for Disease Control and                                           MS C–34, Cincinnati, Ohio 45226–1998.                                   chemical? If not, what specific
                                              Prevention announces the availability of                                     Instructions: All information received                               information is missing from the
                                              three (3) draft Immediately Dangerous to                                  in response to this notice must include                                 document?
                                              Life or Health (IDLH) Value Profiles                                      the agency name and docket number                                         2. Are the rationale and logic behind
                                              now available for public comment for                                      [CDC–2018–0055; NIOSH 156–D]. All                                       the derivation of an IDLH value for a
                                              the chemicals bromine trifluoride,                                        relevant comments received will be                                      specific chemical clearly explained? If
                                              chlorine trifluoride, and ethylene                                        posted without change to                                                not, what specific information is needed
                                              dibromide. To view the notice and                                         www.regulations.gov, including any                                      to clarify the basis of the IDLH value?
                                              related materials, visit                                                  personal information provided. For                                        3. Are the conclusions supported by
                                              www.regulations.gov and enter CDC–                                        access to the docket to read background                                 the data?
                                              2018–0055 in the search field and click                                   documents or comments received, go to                                     4. Are the tables clear and
                                              ‘‘Search.’’                                                               www.regulations.gov. All information                                    appropriate?
                                                                                                                        received in response to this notice will                                  5. Is the document organized
                                              Table of Contents                                                         also be available for public examination                                appropriately? If not, what
                                              •   Dates                                                                 and copying at the NIOSH Docket                                         improvements are needed?
                                              •   Addresses                                                             Office, 1150 Tusculum Avenue, Room                                        6. Are you aware of any scientific data
                                              •   For Further Information Contact                                       155, Cincinnati, OH 45226–1998.                                         reported in governmental publications,
                                              •   Supplementary Information                                             FOR FURTHER INFORMATION CONTACT:
                                              •   Background
                                                                                                                                                                                                databases, peer-reviewed journals, or
                                                                                                                        R. Todd Niemeier, NIOSH, Robert A.                                      other sources that should be included
                                              •   Reference
                                                                                                                        Taft Laboratories, MS–C32, 1090                                         within this document?
                                              DATES:Electronic or written comments                                      Tusculum, Cincinnati, OH 45226,                                           NIOSH seeks comments on 3 draft
                                              must be received by August 7, 2018.                                       telephone (513) 533–8166 (not a toll free                               IDLH values and IDLH Value Profiles.
                                              ADDRESSES:  You may submit comments,                                      number).                                                                The draft IDLH Value Profiles were
                                              identified by CDC–2018–0055 and                                           SUPPLEMENTARY INFORMATION: NIOSH is                                     developed to provide the scientific
                                              docket number NIOSH 156–D, by any of                                      requesting technical reviews of the three                               rationale behind derivation of IDLH
                                              the following methods:                                                    (3) draft IDLH Value Profiles. To                                       values for the following chemicals:

                                                                                 Document No.                                                                                     Chemical                                              CAS No.

                                              C–01 ........................................................................................   Bromine Trifluoride ..................................................................    (7787–71–5)
                                              C–02 ........................................................................................   Chlorine Trifluoride ..................................................................   (7790–91–2)
                                              C–03 ........................................................................................   Ethylene Dibromide .................................................................       (106–93–4)



                                                Each IDLH Value Profile provides a                                        2. Update the scientific bases and risk                                  2. Identification of critical adverse
                                              detailed summary of the health hazards                                    assessment methodology used to derive                                   effects.
                                              of acute exposures to high airborne                                       IDLH values from quality data.                                             3. Identification of a POD.
                                              concentrations and the rationale for the                                    3. Provide transparency behind the
                                              proposed IDLH value with the                                              rationale and derivation process for                                      4. Application of appropriate UFs,
                                              chemical(s) of interest.                                                  IDLH values.                                                            based on the study and POD.
                                                Background: In 2013, NIOSH                                                4. Demonstrate how scientifically                                       5. Determination of the final risk
                                              published Current Intelligence Bulletin                                   credible IDLH values can be derived                                     value.
                                              (CIB) 66—Derivation of Immediately                                        from available data resources.
                                                                                                                          The IDLH methodology is based on a                                    Reference
                                              Dangerous to Life or Health (IDLH)
                                              Values [NIOSH 2013]. Since the                                            weight-of-evidence approach that                                        NIOSH [2013]. Current Intelligence Bulletin
                                              establishment of the IDLH values in the                                   applies scientific judgment for critical                                   66: Derivation of immediately dangerous
                                                                                                                        evaluation of the quality and                                              to life or health (IDLH) values.
                                              1970s, NIOSH has continued to review
                                                                                                                        consistency of scientific data and in                                      Cincinnati, OH: U.S. Department of
                                              available scientific data to improve the
                                                                                                                        extrapolation from the available data to                                   Health and Human Services, Centers for
                                              protocol used to derive acute exposure
                                                                                                                        the IDLH value. The weight-of-evidence                                     Disease Control and Prevention, National
                                              guidelines, in addition to the chemical-
                                                                                                                        approach refers to critical examination                                    Institute for Occupational Safety and
                                              specific IDLH values. The information
                                                                                                                        of all available data from diverse lines                                   Health, DHHS (NIOSH) Publication
                                              presented in this CIB represents the
                                                                                                                        of evidence and the derivation of a                                        2014–100.
                                              most recent update of the scientific                                      scientific interpretation on the basis of
amozie on DSK3GDR082PROD with NOTICES1




                                              rationale and the methodology (hereby                                                                                                               Dated: June 5, 2018.
                                                                                                                        the collective body of data, including its
                                              referred to as the IDLH methodology)                                      relevance, quality, and reported results.                               John J. Howard,
                                              used to derive IDLH values. The                                           Conceptually, the derivation process for                                Director, National Institute for Occupational
                                              primary objectives of this document are                                   IDLH values is similar to that used in                                  Safety and Health, Centers for Disease Control
                                              to:                                                                       other risk-assessment applications,                                     and Prevention.
                                                1. Provide a brief history of the                                       including these steps:                                                  [FR Doc. 2018–12364 Filed 6–7–18; 8:45 am]
                                              development of IDLH values.                                                 1. Hazard characterization.                                           BILLING CODE 4163–19–P




                                         VerDate Sep<11>2014         16:53 Jun 07, 2018        Jkt 241001       PO 00000       Frm 00046       Fmt 4703      Sfmt 4703     E:\FR\FM\08JNN1.SGM            08JNN1



Document Created: 2018-06-08 01:21:57
Document Modified: 2018-06-08 01:21:57
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionRequest for comments.
DatesElectronic or written comments must be received by August 7, 2018.
ContactR. Todd Niemeier, NIOSH, Robert A. Taft Laboratories, MS-C32, 1090 Tusculum, Cincinnati, OH 45226, telephone (513) 533-8166 (not a toll free number).
FR Citation83 FR 26685 

2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR